Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
08/05/2025
After the Federal Reserve kept interest rates unchanged, the US dollar index has slightly declined, falling by 0.15% to 99.489.
Latest
1 m ago
, General Manager of Shanxi Jincheng Department Store Textile Co., Ltd., is under review and investigation.
1 m ago
The Ministry of Natural Resources and China Meteorological Administration jointly issued a geological disaster meteorological risk alert at 18:00 on May 8th. It is expected that from 20:00 on May 8th to 20:00 on May 9th, some areas in the eastern part of Jiangxi, southern part of Hunan, central and northern parts of Guangdong, and northeastern parts of Guangxi have a higher risk of geological disasters.
2 m ago
Extreme Krypton Group: Received a preliminary non-binding acquisition letter from Geely Automobile Holdings Limited.
2 m ago
Ecarx Group: Receives preliminary non-binding acquisition intention letter from Geely Automobile Holdings Limited.
2 m ago
AstraZeneca's new small molecule drug factory in Wuxi officially started construction on May 8th. The new factory has a total investment of 475 million US dollars, covers an area of approximately 30,000 square meters, and will be equipped with two sets of advanced tablet continuous manufacturing process equipment and seven sustainable drug packaging production lines. It will mainly produce AstraZeneca's cardiovascular innovative drugs in the pipeline and is expected to start production in the fourth quarter of 2028. This is a further deepening of AstraZeneca's supply chain layout in China following the completion of the main body of the first phase of the construction of the Qingdao inhaled aerosol production supply base last month (First Financial Daily).
See all latest